






In Other News
New RT-LAMP Assay Offers Affordable and Reliable Pathogen Detection for Resource-Limited Settings
New Biomarker Panel to Enable Early Detection of Pancreatic Cancer
Ultrarapid Whole Genome Sequencing for Neonatal and Pediatric Patients Delivers Results In 48 Hours
2025 COMPAMED Innovation Forum Highlights Pioneering Work in Cancer Diagnostics
AI-Enabled Blood Test Demonstrates Diagnostic, Prognostic and Predictive Utility Across Cancer Continuum
Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation
Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer
Ultra-Sensitive Biosensor Based on Light and AI Enables Early Cancer Diagnosis
DNA Methylation Signatures of Aging Could Help Assess Mortality Risk
Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Response Induction
Ultra-Sensitive Biosensor Based on Light and AI Enables Early Cancer Diagnosis
Molecular Diagnostics System Provides Lab-Quality Results at POC
Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes
Cellular Signature Identifies Patients with Treatment Resistant Prostate Tumors
AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care
MCED Could Be Valuable Supplement to Traditional Cancer Screening Approaches
AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care
Low-Cost Biosensing Technology Detects Disease Biomarkers in Minutes
Newly-Cleared Technology a Game Changer for Diagnosis of Lyme Disease
Innovative Liquid Biopsy Test Uses RNA to Detect Early-Stage Cancer
Quanterix Completes Acquisition of Akoya Biosciences
AI Tool Enhances Interpretation of Tissue Samples by Pathologists
Rapid Tests for Chagas Disease Improves Diagnostic Access